Growth and Adiposity in Newborns: The Influence of Prenatal DHA Supplementation
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/28/2018 |
| Start Date: | November 1, 2017 |
| End Date: | February 28, 2023 |
| Contact: | Beth Kerling, MS, RD |
| Email: | ekerling@kumc.edu |
| Phone: | 913-588-5743 |
The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who
took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to
24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to
24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
Participants for this study are invited from the parent study, ADORE. Eligibility listed
reflects criteria for the ADORE study.
Inclusion Criteria:
- Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA
- Available by telephone
Exclusion Criteria:
- Expecting multiple infants
- Gestational age at baseline <12 weeks or >20 weeks
- Unable or unwilling to agree to consume capsules until delivery
- Unwilling to discontinue use of another prenatal supplement with DHA that contains ≥
200 mg DHA
- Women with allergy to any component of DHA product (including algae), soybean oil or
corn oil
We found this trial at
1
site
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
